BryanKyleKeeMD

PubMed

• Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
  Abdelrahman Yousef, Mahmoud Yousef, Mohammad A Zeineddine, Aditya More, Mohammad Fanaeian, Saikat Chowdhury, Mark Knafl, Paul Edelkamp, Ichiaki Ito, Yue Gu, Vinay Patt...> ;JAMA Network Open. 2024 Feb 5
• Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
  Simmons, K., Thomas, J., Ludford, K., Willis, J., Higbie, V., Raghav, K., Johnson, B., Dasari, A., Kee, B., Parseghian, C., Lee, M., Le, P., Morelli, M., Shen, J., Ben...> ;Cancer Research Communications. 2023 Dec 11
• 9 citations
  The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma.
  Abdelrahman Yousef, Mahmoud Yousef, Mohammad Zeineddine, Aditya More, Saikat Chowdhury, Mark Knafl, Paul Edelkamp, Ichiaki Ito, Yue Gu, Vinay Pattalachinti, Zahra Alav...> ;Medrxiv. 2023 Sep 11
• Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing.
  Stefania Napolitano, Aparna R Parikh, Jason Henry, Christine M Parseghian, Jason Willis, Kanwal P Raghav, Van K Morris, Benny Johnson, Bryan K Kee, Arvind N Dasari, Mi...> ;JCO Precision Oncology. 2023 Sep 1
• A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 ...
  Sarina A Piha-Paul, Chieh Tseng, Hai T Tran, Meng Gao, Daniel D Karp, Vivek Subbiah, Apostolia Maria Tsimberidou, Jitesh D Kawedia, Siqing Fu, Shubham Pant, Timothy A ...> ;Cancer Chemotherapy and Pharmacology. 2023 Aug 1
• 5 citations
  Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
  Apostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson, Regina Mendrzyk, Amir Alpert, Claudia Wagner, Anna Nowak, Katrin Aslan, Arun Satelli, Fabian Richter, Sab...> ;Cancer Immunology Research. 2023 Jul 5
• 24 citations
  Survival improvement for patients with metastatic colorectal cancer over twenty years.
  Fadl A Zeineddine, Mohammad A Zeineddine, Abdelrahman Yousef, Yue Gu, Saikat Chowdhury, Arvind Dasari, Ryan W Huey, Benny Johnson, Bryan Kee, Michael S Lee, Maria Pia ...> ;NPJ Precision Oncology. 2023 Feb 13
• Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.
  Jennifer S Davis, Janelle C Chavez, Melissa Kok, Yazmin San Miguel, Hwa Young Lee, Henry Henderson, Michael J Overman, Van Morris, Bryan Kee, David Fogelman, Shailesh ...> ;JAMA Network Open. 2022 Oct 3
• 7 citations
  Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer.
  Van K Morris, Michael J Overman, Michael Lam, Christine M Parseghian, Benny Johnson, Arvind Dasari, Kanwal Raghav, Bryan K Kee, Ryan Huey, Robert A Wolff, John Paul Sh...> ;Cancer Research Communications. 2022 Sep 1
• 17 citations
  Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
  Benny Johnson, Cara L Haymaker, Edwin R Parra, Luisa Maren Solis Soto, Xuemei Wang, Jane V Thomas, Arvind Dasari, Van K Morris, Kanwal Raghav, Eduardo Vilar, Bryan K K...> ;Journal for Immunotherapy of Cancer. 2022 Aug 1
• Clinical and pathologic features correlated with rare favorable survival in patients withmutated colorectal cancer.
  Van Morris, Bryan Kee, Michael Overman, Arvind Dasari, Kanwal Raghav, Benny Johnson, Christine Parseghian, Robert A Wolff, Naveen Garg, Cathy Eng, Scott Kopetz> ;Journal of Gastrointestinal Oncology. 2022 Apr 1
• 12 citations
  PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers.
  Ecaterina Elena Dumbrava, S.G. Call, Haojie Huang, A.L. Stuckett, Kiran Madwani, Abha Adat, David S. Hong, Sarina Anne Piha-Paul, Vivek Subbiah, Daniel D. Karp, Siquin...> ;ESMO Open. 2021 Oct 1
• 5 citations
  Fertility discussions in young adult stage III colorectal cancer population: a single-center institution experience.
  Jane E. Rogers, Terri L. Woodard, Arvind Dasari, Bryan K. Kee, Prajnan Das, Brian K. Bednarski, John M. Skibber, Miguel A. Rodriguez-Bigas, Cathy Eng> ;Supportive Care in Cancer. 2021 May 28
• 33 citations
  Comprehensive Clinical and Molecular Characterization of KRASG12C-Mutant Colorectal Cancer.
  Jason Henry, Oluwadara Coker, Saikat Chowdhury, John Paul Shen, Van K. Morris, Arvind Dasari, Kanwal Pratap Singh Raghav, Maliha Nusrat, Bryan K. Kee, Christine Megerd...> ;JCO Precision Oncology. 2021 Apr 6
• 21 citations
  Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases.
  Preeti Kanikarla Marie, Cara Haymaker, Edwin R. Parra, Young Uk Kim, Rossana Lazcano, Swati Gite, Daniele Lorenzini, Ignacio I. Wistuba, Rebecca S. S. Tidwell, Xiaofei...> ;Clinical Cancer Research. 2021 Apr 2
• 16 citations
  Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer
  Shailesh Advani, Michael D. Swartz, Jonathan M. Loree, Jennifer S. Davis, Amir Mehvarz Sarsashek, Michael Lam, Michael Sangmin Lee, Jan Bressler, David S. Lopez, Carri...> ;Clinical Colorectal Cancer. 2021 Jun 1
• Bevacizumab does not influence the efficacy of partial splenic embolization in the management of chemotherapy-induced hypersplenism
  Alexandre A. Jácome, Aki Ohinata, Armeen Mahvash, Michael J. Overman, Bryan K. Kee, David R. Fogelman, Van K. Morris, Benny Johnson, Nicole D. Rothschild, Robert A. Wo...> ;Clinical Colorectal Cancer. 2020 Jun 12
• 4 citations
  FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall Survival.
  Alexandre A. Jácome, Bryan K. Kee, David R. Fogelman, Arvind Dasari, Imad Shureiqi, Kanwal Pratap Singh Raghav, Van K. Morris, Benny Johnson, Michael J. Overman, Rober...> ;Clinical Colorectal Cancer. 2020 Jun 5
• 2 citations
  Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
  Shailesh Advani, Quilling Shi, Michael J. Overman, Jonathan M. Loree, Michael Nguyen Minh Chau Lam, Van K. Morris, Imad Shureiqi, Bryan K. Kee, Arvind Dasari, Eduardo ...> ;Clinical Colorectal Cancer. 2020 Mar 1
• 13 citations
  Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
  Krittiya Korphaisarn, Van K. Morris, Jenifer S Davis, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Arvind Dasari, Kanwal Pratap Singh Raghav, Imad Shureiqi, Me...> ;British Journal of Cancer. 2019 Sep 10
• 20 citations
  Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer.
  Benny Johnson, Jonathan M. Loree, Alexandre A. Jácome, Shehara Mendis, Muddassir A. Syed, Van K. Morris, Christine Megerdichian Parseghian, Arvind Dasari, Shubham Pant...> ;JCO Precision Oncology. 2019 Aug 5
• 1 citations
  Corrigendum: Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer (Annals of Onc...
  Michael J. Overman, Liana Adam, Kanwal Pratap Singh Raghav, Jing Wang, Bryan K. Kee, David R. Fogelman, Cathy Eng, Eduardo Vilar, Rachna T. Shroff, Arvind Dasari, Robe...> ;Annals of Oncology. 2019 Mar 1
• Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-challenge.
  Parseghian, C. M.,Loree, J. M.,Morris, V. K.,Liu, X.,Clifton, K. K.,Napolitano, S.,Henry, J. T.,Pereira, A. A.,Vilar, E.,Johnson, B.,Kee, B.,Raghav, K.,Dasari, A.,Wu, ...> ;Ann. Oncol.. 2018 Nov 22
• 10 citations
  Physician interpretation of genomic test results and treatment selection.
  Lauren Brusco, Chetna Wathoo, Kenna R. Mills Shaw, Vijaykumar Holla, Ann Marie Bailey, Amber Johnson, Yekaterina B. Khotskaya, Beate C. Litzenburger, Nora S. Sanchez, ...> ;Cancer. 2018 Mar 1
• 21 citations
  Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
  M J Overman, L Adam, K Raghav, J Wang, B Kee, D Fogelman, C Eng, E Vilar, R Shroff, A Dasari, R Wolff, J Morris, E Karunasena, T R Pisanic 2nd, N Azad, S Kopetz> ;Annals of Oncology. 2018 Jan 1
• Join now to see all

Journal Articles

• Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-Challenge  
  B Kee, N Garg, M J Overman, V K Morris, B Johnson, J Wu, J H Strickler, S Kopetz, X Liu, D S Hong, Annals of Oncology